See All Slides -

Slides

Presentation TCT 2025

The Data is Strong and Worth Your Time

Presenter: Sandeep Nathan

October 27, 2025

Presentation TCT 2025

TCT 466: Regenerated endothelium with protective function after drug-coated balloon

Presenter: Takamasa Tanaka

October 27, 2025

Presentation TCT 2025

TCT 258: Age and Sex Modify Long-Term Benefit of Microaxial Flow Pump Treatment in Cardiogenic Shock: A DanGer Shock Analysis

Presenter: Anika Klein

October 27, 2025

Presentation TCT 2025

Tips and Tricks for Managing Multivessel Disease with Left Main Involvement

Presenter: Ioannis Iakovou

October 27, 2025

Presentation TCT 2025

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

Presenter: Yan Wang

October 27, 2025

Presentation TCT 2025

Up to 50% of Patients Have the Post-PE Syndrome - Could Catheters Help?

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

Presenter: John Gregson

October 27, 2025

Presentation TCT 2025

TCT 1481: When Surgery Is Not an Option: Transcatheter Mitral Valve-in-MAC Replacement

Presenter: Iulian Calin

October 27, 2025

Presentation TCT 2025

Case 2. Double Whammy: Under-expanded Stent and Calcific Neo-Atherosclerosis

Presenter: Ram Vijayaraghavan

October 27, 2025

Presentation TCT 2025

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

Presenter: Jacob Eifer Moeller

October 27, 2025

Advertisement

Slides

The Data is Strong and Worth Your Time

TCT 466: Regenerated endothelium with protective function after drug-coated balloon

TCT 258: Age and Sex Modify Long-Term Benefit of Microaxial Flow Pump Treatment in Cardiogenic Shock: A DanGer Shock Analysis

Tips and Tricks for Managing Multivessel Disease with Left Main Involvement

Evaluation of the Safety and One-Year Efficacy of the Novel Neoblazar® Transcatheter Edge-to Edge Repair System for Symptomatic Severe Tricuspid Regurgitation (Dawneo Medical Technology)

Up to 50% of Patients Have the Post-PE Syndrome - Could Catheters Help?

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

TCT 1481: When Surgery Is Not an Option: Transcatheter Mitral Valve-in-MAC Replacement

Case 2. Double Whammy: Under-expanded Stent and Calcific Neo-Atherosclerosis

The Contemporary Management of Cardiogenic Shock in the Post DanGer-Shock Era?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content